RIGL: Rigel Pharma Kompaniya qiymatining sof foydaga nisbati
Rigel Pharmaceuticals (RIGL) onkologik va ghematologik patologiyalarga qarshi kurashish uchun innovatsion kichik molekulali terapiyalarni ishlab chiqadi. Tajribali rahbariyat mahsulotlarni tijoratlashtirishni tadqiqot va ishlanmalar faoliyati bilan samarali muvozanatga soladi. Kompaniyaning P/E tendentsiyasi aktivning bozor qiymatini namoyish etadi, 2.70 qiymati esa ushbu holatni aks ettiradi. Biroq, patentlarga bog'liqlik va yangi formulalarni sinovdan o'tkazish xarajatlari to'liq moliyaviy mustaqillikka erishishga to'sqinlik qilmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_RIGL_-_Rigel-Pharmaceuticals_-_PE-Multiple "RIGL: Rigel Pharmaceuticals Biznesning o‘zini qoplash muddati 04.07.2022 - 12.11.2026 | 👁️GURU.Markets👁️")
Rigel Pharmaceuticals Inc (RIGL) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Rigel Pharmaceuticals|RIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Rigel Corp|RIGL - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Rigel Pharmaceuticals, Inc.|RIGL - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Rigel Pharmaceuticals|Oraliq qoplash koeffitsiyenti rigel.com
- foyda va bozor multiplikatorlari tafsilotlari:
RIGL - Sof foyda|Kompaniya foydasi prognozi Rigel Pharmaceuticals|RIGL - P/E multiplikatori|Forvard narx-foyda multiplikatori Rigel Pharma|RIGL - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Rigel Pharmaceuticals, Inc.|RIGL - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Rigel Pharmaceuticals|RIGL - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi rigel.com|RIGL - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Rigel Pharmaceuticals
Kompaniyaning har tomonlama tahlili:rigel.com RIGL
Investitsiya xatarlarini minimallashtirish Rigel Pharmaceuticals (RIGL) kompaniyasining bozor kapitallashuvini uning sof foyda keltirishga bo'lgan haqiqiy qobiliyati bilan, ayniqsa laboratoriya skriningini robotlashtirish bilan bog'liq xarajatlarni hisobga olgan holda solishtirishni talab qiladi. Jori P/E koeffitsiyentini tahlil qilish orqali investor biznesning qoplash muddatini aniqlaydi va aksiya narxining kompaniyaning har bir aksiya uchun joriy samaradorligi bilan qanchalik asoslanganligini baholaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TRML (Tourmaline)|PGEN: P/E multiplikatori|PHAR - Biznesning o‘zini qoplash muddati|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|UPB - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori ZBIO|IMNM - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|kalvista.com - Narxning foydaga nisbati|SEPN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PVLA (Pieris Pharma)|Savara Corp (SVRA) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati ANAB (AnaptysBio Inc.)|ATXS (Astria Therapeutics) - P/E multiplikatori|ENGN: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori RAPT|P/E multiplikatori aerovatetx.com (JBIO)|Narxning foydaga nisbati Aclaris ACRS|Kompaniya qiymatining sof foydaga nisbati KYTX|TLSA - Narxning foydaga nisbati|cabalettabio.com (CABA) - Narx-foyda koeffitsiyenti|VTYX: P/E multiplikatori|Theratechnologies, Inc. (THTX) - P/E multiplikatori|AVTX (Avalo Therapeutics Inc.) - P/E multiplikatori|Narx-foyda koeffitsiyenti Eledon Pharmaceuticals, Inc (ELDN)|P/E multiplikatori AGEN|CLYM - Kapitalizatsiyaning foydaga nisbati|Zura Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori aTyr Pharma Inc ATYR|ADAG: Narx-foyda koeffitsiyenti|ImageneBio Inc - Bozor narxining sof foydaga nisbati|STTK: P/E multiplikatori|EQ - Biznesning o‘zini qoplash muddati|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|Narx-foyda koeffitsiyenti Immunic Inc (IMUX)|P/E multiplikatori ATRA|P/E multiplikatori inflarx.de (IFRX)|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|Adicet Bio Inc. - Narxning foydaga nisbati|CELU - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati INmune Bio Inc INMB|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Kezar Life Sciences Inc - Kompaniya qiymatining sof foydaga nisbati|SABS (SAB Biotherapeutics) - P/E multiplikatori|akaritx.com (AKTX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ENLV|q32bio.com (QTTB) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati GeoVax Labs Inc GOVX|Edesa Biotech Corp - Narxning foydaga nisbati|IBIO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati CARM|XTLB: P/E multiplikatori|Bolt Biotherapeutics, Inc. - Kompaniya qiymatining sof foydaga nisbati|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|ADTX (aditxt.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati GRI Bio GRI|XRTX - Narx-foyda koeffitsiyenti|ReShape Lifesciences - P/E multiplikatori|REVB - P/E multiplikatori|INDP (Indaptus Therapeutics) - Narx-foyda koeffitsiyenti|scinai.com - Kompaniya qiymatining sof foydaga nisbati|CALI (CalciMedica Inc) - P/E multiplikatori|Affimed Therapeutics (AFMD) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Allakos Inc. (ALLK)|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS - Narx-foyda koeffitsiyenti|OCEA: Narx-foyda koeffitsiyenti|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
